Features & Analyses

Current sanctions, the risk of future sanctions, and foreign investment controls are some of the increasingly prominent challenges facing merger & acquisition (M&A) deals involving Chinese parties this year. While there is no universal solution for each transaction, there are still ways parties and lawyers can minimize the risk of problems arising.

Casper Sek of Jingtian & Gongcheng examines new implementation guidelines for data transfers and explains how these fit into the wider context of cooperation within the Greater Bay Area, as well as how companies will benefit

Former China COO of Morgan Stanley compares the challenges of being a senior executive at a boutique private equity firm against that of a bulge bracket investment bank

Wei Huang, Wendy Zhou and Lujia Yu, antitrust specialists at Beijing Tian Yuan Law Firm, examine the landmark Supreme People's Court judgment in re Yangtze River Pharma et al. v HIPI Pharma et al

A recent change in rules amends the jurisdiction of the IP tribunal of China's highest court, potentially freeing up judicial resources. Fang Qi and Danlei Wu of Fangda Partners review the new rules and their impact

Once the bill passes, Singapore will join such countries as China, Japan, the U.S., Australia and the U.K., which have comparable investment regulations.

Fang Qi and Danlei Wu of Fangda Partners examine the Supreme People's Court's annual summary of its landmark anti-monopoly and anti-unfair competition cases. This year's cases reveal the Court's focus on business ethics among other trends

When foreign investment strategy changes, many important issues can arise, not least in the area of intellectual property rights. David Lin and Shen Yang of DOCVIT Law Firm explore these issues, and underline the importance of arranging appropriate methods to dispose of relevant rights

Casper Sek of Jingtian & Gongcheng examines the implications of a new set of draft provisions aimed at regulating and facilitating the cross-border flow of data